Lu, B., Lu, C., Sun, Z., Qu, C., Chen, J., Hua, Z., . . . Zhang, J. (2019). Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma. J Int Med Res.
シカゴスタイル引用形Lu, Bin, Chaoyun Lu, Zheng Sun, Caiping Qu, Ji Chen, Zhaolai Hua, Ruimin Tong, , Junfeng Zhang. "Combination of Apatinib Mesylate and Second-line Chemotherapy for Treating Gastroesophageal Junction Adenocarcinoma." J Int Med Res 2019.
MLA引用形式Lu, Bin, et al. "Combination of Apatinib Mesylate and Second-line Chemotherapy for Treating Gastroesophageal Junction Adenocarcinoma." J Int Med Res 2019.
警告: この引用は必ずしも正確ではありません.